Comprehensive pan-cancer analysis and experiments revealed R3HDM1 as a novel predictive biomarker for prognosis and immune therapy response
Abstract Background: R3HDM1, an RNA binding protein with one R3H domain, remains uncharacterized in terms of its association with tumor…